#USA #New York #Class Action #Bronstein Gewirtz #Dentsply Sirona

Dentsply Sirona Inc. Faces Class Action Lawsuit

In recent news, a substantial class action lawsuit has been brought against Dentsply Sirona Inc., a prominent company in the dental industry. The legal firm Bronstein, Gewirtz & Grossman, LLC has made an announcement urging investors who have experienced significant losses to join this collective action.

The Nut of the Matter

Dentsply Sirona, which trades on NASDAQ under the ticker symbol XRAY, is facing serious allegations relating to the federal securities laws. This lawsuit has been initiated on behalf of all individuals and entities that purchased Dentsply securities between December 1, 2022, and November 6, 2024. The complaint states that Dentsply concealed several critical facts that materially misrepresented the company’s operations and financial condition.

Specific Allegations

The complaint outlines a series of alleged deceptive practices by Dentsply Sirona. Notably, it claims that the company targeted low-income individuals who lacked access to essential dental care. This practice resulted in patients with pre-existing dental issues being accepted into treatment programs, particularly regarding the Byte system offered by Dentsply. The lawsuit highlights concerns about inadequate procedures that did not prevent contraindicated patients from entering treatment programs.

Moreover, it asserts that Dentsply was aware of numerous reports regarding injuries stemming from the Byte aligners, and yet failed to alert the FDA or conduct proper investigations into these complaints. This alarming trend included an increasing number of serious injury reports linked to the Byte device, yet Dentsply appears to have disregarded its responsibility to notify the FDA of such injuries.

What Investors Should Know

For those affected, there’s an opportunity to take part in this class action. According to Bronstein, Gewirtz & Grossman, individuals who believe they lost money in Dentsply can visit their firm’s website for more details and to review the complaint. If interested in serving as a lead plaintiff, investors must submit requests by January 27, 2025. However, it is essential to note that participation in any financial recovery does not require one to take on the role of lead plaintiff.

No Financial Risk for Participants

One of the appealing aspects of this legal action is the contingency fee model. This means that the law firm only collects fees if there is a successful recovery. In this case, costs including attorney’s fees will only apply if the court rules in favor of the plaintiff group. This arrangement allows every investor to join without the concern of upfront legal expenses.

Why Choose Bronstein, Gewirtz & Grossman?

This nationally recognized law firm has built a solid reputation by representing investors in securities fraud class actions and similar lawsuits. With a history of recovering substantial sums for investors across the country, the firm expresses confidence in building a strong case against Dentsply Sirona.

In summary, those who have invested in Dentsply Sirona within the specified time frame are encouraged to evaluate their legal options. With the allegations indicating potential misconduct, participating in this class action could serve not just to recover losses but also to hold the firm accountable for its actions.

For more information, you can reach out to Bronstein, Gewirtz & Grossman directly. As the deadline approaches, those interested should act promptly to assert their rights and possibly recover their losses sustained during the alleged period of wrongdoing.